JPRN-jRCT2051220047招募中3 期
[M19-388] An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial - Venetoclax Extension Study
Sumiko Okubo0 个研究点目标入组 550 人开始时间: 2022年6月10日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 550
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Subject has been enrolled and dosed in an ongoing venetoclax study and continues to tolerate and derive benefit from the study drug.
- •- Male subject agrees to refrain from sperm donation.
- •- Female subjects must not be pregnant or breastfeeding.
排除标准
- 未提供
研究者
相似试验
招募中
1 期
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical TrialChronic lymphocytic leukemiaNon-Hodgkin's lymphomaAcute Myeloid Leukemia, Acute Lymphocytic LeukemiaMedDRA version: 21.0Level: LLTClassification code: 10008976Term: Chronic lymphocytic leukemia Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10054695Term: Waldenstrom's macroglobulinemia Class: 10029104MedDRA version: 22.0Level: PTClassification code: 10029547Term: Non-Hodgkin's lymphoma Class: 100000004864MedDRA version: 21.0Level: LLTClassification code: 10028228Term: Multiple myeloma Class: 10029104Multiple MyelomaCTIS2022-501522-38-00Abbvie Deutschland GmbH & Co. KG165
进行中（未招募）
1 期
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical TrialMultiple MyelomaEUCTR2018-004356-38-SEAbbVie Deutschland GmbH & Co. KG550
进行中（未招募）
1 期
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical TrialMultiple MyelomaEUCTR2018-004356-38-ATAbbVie Deutschland GmbH & Co. KG550
进行中（未招募）
1 期
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical TrialChronic lymphocytic leukemiaNon-Hodgkin's lymphomaT prolymphocytic leukemiaChronic myeloid leukemiaWaldenstrom's macroglobulinemia lymphoma and Relapsed/refractory pediatric malignanciesAcute Myelogenous Leukemia (AML)MedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10008976Term: Chronic lymphocytic leukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10009015Term: Chronic myeloid leukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10054695Term: Waldenstrom's macroglobulinemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Multiple MyelomaEUCTR2018-004356-38-DKAbbVie Deutschland GmbH & Co. KG550
进行中（未招募）
1 期
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical TrialChronic lymphocytic leukemiaNon-Hodgkin's lymphomaT prolymphocytic leukemiaChronic myeloid leukemiaWaldenstrom's macroglobulinemia lymphoma and Relapsed/refractory pediatric malignanciesAcute Myelogenous Leukemia (AML)MedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10008976Term: Chronic lymphocytic leukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10009015Term: Chronic myeloid leukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10054695Term: Waldenstrom's macroglobulinemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Multiple MyelomaEUCTR2018-004356-38-PLAbbVie Deutschland GmbH & Co. KG550